References
- SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
- DettlaffKStawnyMOgrodowczykMFormulation and characterization of EGCG for the treatment of superficial bladder cancerInt J Mol Med201740232933628627636
- BabjukMBurgerMZigeunerREuropean Association of UrologyEAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013Eur Urol201364463965323827737
- ChenHToyookaSGazdarAFHsiehJTEpigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell linesJ Biol Chem200327853121313012446720
- DoteHToyookaSTsukudaKAberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancerClin Cancer Res20041062082208915041729
- YanoMToyookaSTsukudaKAberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancersInt J Cancer20051131596615386433
- ZhangXLiNLiXLow expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinomaJ Gastroenterol Hepatol20122761117112522168621
- DuanYFLiDFLiuYHDecreased expression of DAB2IP in pancreatic cancer with wild-type KRASHepatobiliary Pancreat Dis Int201312220420923558076
- WangZTsengCPPongRCThe mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2J Biol Chem200227715126221263111812785
- XieDGoreCLiuJRole of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasisProc Natl Acad Sci U S A201010762485249020080667
- ShenYJKongZLWanFNDownregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancerCancer Sci2014105670471224684735
- XieDGoreCZhouJDAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosisProc Natl Acad Sci U S A200910647198781988319903888
- WuKWangBChenYDAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signalingCell Signal201527122515252326410305
- MinJZaslavskyAFedeleGAn oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaBNat Med201016328629420154697
- ZhuJNWuKJGuanZFDAB2IP expression in bladder transitional cell carcinoma and its correlation with clinical outcomeSichuan Da Xue Xue Bao Yi Xue Ban201445459159425286682
- FristrupNUlhoiBPBirkenkamp-DemtroderKCathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancerAm J Pathol201218051824183422449953
- ChoiWPortenSKimSIdentification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapyCancer Cell201425215216524525232
- ZhouJNingZWangBDAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosisCell Death Dis20156e195526512963
- ChenCLCenLKohoutJSignal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survivalMol Cancer200877818939995
- ZhaoDBesserAHWanderSACytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulationOncogene201534435447545925684140